$PFE Potential Vaccine! - Announce Early Positive Data from an Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate Against SARS-CoV-2

BNT162b1 is showing strong promise! 

Pfizer is still down 20% from 12 months ago, there is still space to grow!

https://t.co/7IX72cSl29